Clinical Trial: A Phase 1 Clinical Trial to Evaluate the Safety and the Pharmacokinetic Drug-Drug Interaction Between HUC2A-752-A and HUC2A-752-B in Healthy Adults

U.S., Aug. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07784621) titled 'A Phase 1 Clinical Trial to Evaluate the Safety and the Pharmacokinetic Drug-Drug Interaction Between HUC2A-752-A and HUC2A-752-B in Healthy Adults' on Aug. 05.

Brief Summary: This study evaluates the pharmacokinetic drug-drug interactions of repeated co-administration of HUC2A-752-A and HUC2A-752-B compared to monotherapy of each agent in healthy adults

Study Start Date: Oct., 2026

Study Type: INTERVENTIONAL

Condition: Hypertension

Intervention: DRUG: Losartan (COZZAR(R))

HUC2A-752-A

DRUG: Pitavastatin plus Ezetemibe

HUC2A-752-B

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Huons Co., Ltd.

Disclaimer: Curated by HT Sy...